Welcome!
Raffles Medical Group (RMG)
Results
Raffles Medical reports 1HFY2023 earnings of $59.9 mil, up 0.5% y-o-y
Based on current conditions and barring unforeseen circumstances, the directors expect the group to remain profitable in FY2023.
July 31, 2023
Broker's Calls
Stocks like Delfi, Marco Polo Marine and Raffles Medical could benefit from Indonesia's strong economic performance
The sectors to look out for are consumer, commodity, healthcare tourism, plantation and marine-related.
June 13, 2023
Broker's Calls
Brokers' Digest: Food Empire, Lendlease Global Commercial REIT, Raffles Medical Group, SembMarine, Choo Chiang Holdings
See what the analysts have to say this week.
April 01, 2023
Broker's Calls
UOBKH ups Raffles Medical's TP as its transitional care facilities join Singapore's healthcare ecosystem
Raffles Medical Group boasts “healthy margins due to its asset-light nature”, say UOB Kay Hian Research analysts.
March 28, 2023
Broker's Calls
RHB maintains 'buy' on Raffles Medical Group following strong revenue and China's reopening
Covid-19 may be behind, but RHB still sees a lot of life in Raffles Medical Group.
March 24, 2023
Healthcare
Large-cap healthcare stocks: Hefty, hearty and healthy
Covid-19 may be over, but these hospital players are still seeing growth from the economic recovery.
March 09, 2023
Results
Raffles Medical Group sees 2HFY2022 earnings increase by 87.5% y-o-y to $83.8 mil as foreign patients return
RMG has declared a final ordinary dividend of 3.8 cents per share, 35.7% higher y-o-y.
February 27, 2023
Broker's Calls
Analysts positive on Raffles Medical amid stronger-than-expected recovery for 3QFY2022
For 3QFY2022, the group reported revenue growth of 6.5% y-o-y to $199.5 million
November 03, 2022
Results
Raffles Medical Group reports 62.1% surge in 3QFY2022 profit after tax of $38.3 mil
The group says that it expects to remain profitable for the rest of the year based on the current conditions.
October 31, 2022
Broker's Calls
Private hospitals may benefit from rise in Covid-19 cases: DBS
DBS has kept “buy” on Raffles Medical Group and IHH Healthcare with target prices of $1.63 and RM7.90 ($2.37) respectively.
October 25, 2022